Accreditation Criteria : ISO/IEC 17025:2017;CNS 17025:2018
Accreditation Number : 1809
Originally Accredited : 2007.06.20
In 2007, R&D Department of EMO Biomedicine Corp (EMO) has been accredited by Taiwan Accreditation Foundation (TAF) as “Testing Laboratory”, which is in accordance with ISO/IEC 17025. EMO’s accredited scope of testing includes preclinical study and clinical trial. The current certificated test items refer to link below.
Certificated Item : Endotoxin (Drugs)
Accreditation Number : D005
Originally Accredited : 2009.11.20
The research and develop department of EMO Biomedicine Corp (EMO) obtained the certificate of accreditation as a qualified “Drugs and Cosmetics Testing Laboratory” from TFDA in November 2009. This certificate means EMO’s lab has high quality performance on testing technical competence and quality of analysis data.
The Cell Processing Unit (CPU) of EMO Biomedicine obtained approval from MoHW* for the compliance of Good Tissue Practice (GTP) on December 26, 2019. The approval includes processing, culture, and storage of cell-based product. The current cooperated hospital for the cell therapy is Far Eastern Memorial Hospital. Other hospitals are in the processing of application.